Seroprevalence of Transfusion Transmitted Infections among blood donors in a Tertiary care Hospital in Andhra Pradesh

  • C R Sirajunnisa Begum Associate professor, Department of pathology, Apollo Medical college, Murukambattu, Chittoor. Andhra Pradesh.
  • S Nafeesa Banu Assistant Professor, Dept. of Pathology, Mahatma Gandhi Medical college and Research Institute, Pondicherry.
  • Venkatraman J
Keywords: Transfusion Transmitted Infections, HIV, Syphilis, HBV, HCV

Abstract

Background: Blood transfusion is a life-saving procedure as even a single unit of blood and its components can save multiple recipients in need.  Though it’s a safe procedure, the risk of transmission of infections like HIV, syphilis, hepatitis B and hepatitis C are still seen. The objective of this study was to determine the frequency of HBsAg, HCV, HIV, Syphilis and Malaria in various ABO and Rh (D) blood groups donors.Methods: A retrospective study was performed from January 2014 to May 2017 in a blood bank of a tertiary care hospital. A total of 8260 blood units which were collected from both voluntary and replacement donors during the study period were included. Complete donor’s demography and screening status for TTI’s were analysed.Results: Out of 8260 blood donors, 232(2.8%) were positive for TTIs. The overall prevalence of HIV, HBV, HCV and Syphilis was found to be 0.06%, 2.1 % , 0.15% and 0.4% respectively. The highest percentage of prevalence was observed for HBV, followed by syphilis, HCV and HIV. Higher seroprevalence of TTI’s were noted in replacement donors and younger age group between 18 to 30 years.Conclusion: Following strict donor eligibility criteria and effecting high sensitive screening methods can bring down the prevalence of TTI’s. Proper treatment and follow-up counselling can help in preventing further transmission of infections in the community.DOI: 10.21276/APALM.1674

References

1. Jasani J, Patel V , Bhuva K , vavachhani A, Patel H, Falleir J, et al. Sero-prevalence of transfusion transmissible infections among blood donors in a tertiary care hospital. Int J Biol Med Res. 2012; 3(1): 1423-25.
2. Widman FK, Technical Manual America Association of Blood Bank, Anglington USA;1985, PP 325-344.
3. Bhawani Y, Rao PR, Sudhakar V. Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh. Biology and Medicine 2010;2:45-8.
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. Therisk of transfusion-transmitted viral infections. N Engl J Med1996;334:1685-90.
5. Giri PA, Deshpande JD, Phalke DB, Karle LB:Seroprevalence of transfusion transmissible infections among voluntary blood donors at a tertiary care teaching hospital in rural area of India: J.Fam. Med. Primary Care 2012: 1:48-51.
6. Singh N. NAT: Safe Blood, Safe India. Available from: http://www.expresshealthcare.in/200810/knowledge02.shtml. [Last cited on 2010, Jun 14].
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden,treatment, and current and emerging prevention and control measures:A review. J Viral Hepat 2004,11:97-107.
8. Gasiorowicz M, Hurrie M, Russel A, Hoxie N, Vegeront J. Epidemiologictrends in infection, mortality and transplants related to hepatitis C inWisconsin. WMJ 2006;105:34-9.
9. World Health Organization (WHO). Blood Safety Strategy for the African Region. Brazzaville,World Health Organization, Regional Office for Africa(WHOAFR /RC51/9 Rev.1). 2002.
10. Government of India. Drugs and Cosmetics Act. The Gazette of India, New Delhi. 1989.
11. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of Hepatitis C virus, Hepatitis B virus and Human immunodeficiency virus in Delhi blood donors: A hospital based study. Jpn J Dis 2007;60;389-91.
12. Leena MS, Shafe M. Trend and prevalence of transfusion transmitted infections among blood donors in rural teaching institute, South India. Journal of Pathology of Nepal. 2012;2:203-206.
13. Chaudhary V, Agrawal VK, Sexena SK, Upadhyay D, Singh A, Singh SP. Seroprevalence of common transfusion transmissible infections among blood donors in western Uttar Pradesh, India. Int J Med Sci Public Health 2014;3:1381-1384.
14. Mehta D, Vachhani JH, Desai NJ. Seroprevalence of HIV, HBV,HCV and syphilis in blood donors.Indian Journal of Research, 2013;2:2:240-241.
15. Naskar S, Nandy S, Basu K, Basu R. Study of Seroprevalence of HIV, Hepatitis B and C And Syphilis Among Blood Donors In A Tertiary Care Hospital, Kolkata. IOSR Journal of Dental and Medical Sciences. 2013; 11(3): 63-6.
16. Negi G, Gaur DS. Trends of Transfusion Transmissible Diseases Among Blood Donors at Uttarakhand, India. Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine. 2014;39(3):183-186.
17. Kaur H, Mannan R, Manjari M. Seroprevalence of the Blood Borne Infection in Blood Donors: Our 11 Year (2001-2011) Experience in a Tertiary Care Teaching Hospital at Amritsar (Punjab). International Journal of Advanced Research. 2014; 6(2): 967-72.
18. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, HajibeigiB, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007; 10(24): 4461-6.
19. Ahmed MU, Begum HA, Hossain T, Chakraborty P. Incidence of common transfusion transmitted diseases among blood donors. Journal of Armed Forces Medical College, Bangladesh. 2009; 5(1): 4-6.
20. Shrestha AC, Ghimire P, Tiwari BR, Rajkarnikar M. Transfusion-transmissible infections among blood donors in Kathmandu,Nepal. The Journal of Infection in Developing Countries. 2009; 3(10): 794-7.
21. Zheng X, Ding W, Li G, Wu Y, Wu D, Zhu H, et al. Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. Blood Transfusion. 2015; 13(3): 401.
22. Zameer M, Shahzad F, Shafi Khan F, Ali H, Saeed U, Farooq M. Transfusion transmissible infections among healthy blood donors at blood bank from children’s hospital & institute of child health Lahore. Pak Armed Forces Med J 2017; 67(1):131-36.
Published
2018-01-28
Issue
Vol 5 No 1 (2018)
Section
Original Article

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).